Metabolism and disposition of ¹⁴C-granisetron in rat, dog and man after intravenous and oral dosing

S. E. Clarke Department of Drug Metabolism and Pharmacokinetics, Boots Pharmaceuticals, Pennyfoot Street, Nottingham, NG2 3AA, UK

N. E. Austin Department of Drug Metabolism and Pharmacokinetics, Boots Pharmaceuticals, Pennyfoot Street, Nottingham, NG2 3AA, UK

J. C. Bloomer Department of Drug Metabolism and Pharmacokinetics, Boots Pharmaceuticals, Pennyfoot Street, Nottingham, NG2 3AA, UK

R. E. Haddock Drug Metabolism and Pharmacokinetics, Boots Pharmaceuticals, Pennyfoot Street, Nottingham, NG2 3AA, UK

F. C. Higham Pharmaceutical Technologies, SmithKline Beecham Pharmaceuticals, Yew Tree Bottom Road, Epsom, KT18 5XQ, UK

F. J. Hollis Department of Drug Metabolism and Pharmacokinetics, Boots Pharmaceuticals, Pennyfoot Street, Nottingham, NG2 3AA, UK

M. Nash Department of Drug Metabolism and Pharmacokinetics, Boots Pharmaceuticals, Pennyfoot Street, Nottingham, NG2 3AA, UK

P. C. Shardlow Department of Drug Metabolism and Pharmacokinetics, Boots Pharmaceuticals, Pennyfoot Street, Nottingham, NG2 3AA, UK

T. C. Tasker Clinical Pharmacology, SmithKline Beecham Pharmaceuticals, Coldharbour Road, The Pinnacles, Harlow, CM19 5AD, UK

F. R. Woods Worldwide Regulatory Compliance, SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, AL6 9AR, UK

G. D. Allen Department of Drug Metabolism and Pharmacokinetics, Boots Pharmaceuticals, Pennyfoot Street, Nottingham, NG2 3AA, UK

show all

References

Allen A., Asgill C. C., Pierce D. M., Upward J., Zussman B. D. Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5‐HT3 antagonist, in healthy human subjects. European Journal of Clinical Pharmacology 1994; 46: 159–162
PubMed Web of Science ®Google Scholar
Cupissol D. R., Serrou B., Caubel M. The efficacy of granisetron as a prophylactic anti‐emetic and intervention agent in high‐dose cisplatin‐induced emesis. European Journal of Cancer 1990; 26(Suppl. 1)S23–27
PubMed Web of Science ®Google Scholar
Marty M. A comparison of granisetron as a single agent with conventional combination anti‐emetic therapies in the treatment of cytostatic‐induced emesis. The granisetron study group. European Journal of Cancer 1992; 28A(Suppl. 1)S12–16
Google Scholar
Plosker G. L., Goa K. L. Granisetron: a review of its pharmacological properties and therapeutic use as an anti‐emetic. Drugs 1991; 42: 805–824
PubMed Web of Science ®Google Scholar
Sanger G. J., Nelson D. R. Selective and functional 5‐hydroxytryptamine‐3 receptor antagonism by BRL 43694 (granisetron). European Journal of Pharmacology 1989; 159: 113–124
PubMed Web of Science ®Google Scholar
Tomlinson P. W., Jeffery D. J., Filer C. W. A novel technique for assessment of biliary secretion and enterohepatic circulation in the unrestrained conscious rat. Xenobiotica 1981; 11: 863–870
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Metabolism and disposition of ¹⁴C-granisetron in rat, dog and man after intravenous and oral dosing

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Metabolism and disposition of ¹⁴C-granisetron in rat, dog and man after intravenous and oral dosing